CorWave
France - ClichyBiotechnology
Focus: CorWave is a France-based biotechnology company specializing in blood pump devices for advanced heart failure and rare cardiovascular diseases. With 51–200 employees, it operates as a focused medical device/biotech innovator.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Employees
51-200
Open Jobs
9
Should You Work at CorWave?
AI assessmentCorWave is a niche-focused device biotech with meaningful career learning potential in circulatory support, but limited visibility into financials and clinical progress warrants due diligence on runway and milestone timing before commitment.
Why Work Here
- Rare opportunity to work on innovative mechanical circulatory support (blood pump) technology for unmet cardiovascular needs with only 1 active clinical trial indicating early-stage, high-impact potential.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
N/A
Clinical Trials (1)
NCT06907017CorWave LVAS FIH Study
N/AHelp build intelligence for CorWave
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.